HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print May 5, 2008

This Article Full Text Full Text (PDF) All Versions of this Article: jlb.0707499v1 84/2/550    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Sireci, G. Articles by Salerno, A. PubMed PubMed Citation Articles by Sireci, G. Articles by Salerno, A.

(Journal of Leukocyte Biology. 2008;84:550-560.)
© 2008 by Society for Leukocyte Biology

Prophylaxis of lipopolysaccharide-induced shock by -galactosylceramide

Guido Sireci^*,1, Marco Pio La Manna^*, Diana Di Liberto^*, Marco Lo Dico^*, Masaru Taniguchi, Francesco Dieli^* and Alfredo Salerno^*

^* Dipartimento di Biopatologia e Metodologie Biomediche, Università di Palermo, Palermo, Italia; and
Research Unit for Cellular Immunotherapy, RIKEN Research Center for Allergy and Immunology, Yokohama, Kanagawa, Japan

¹ Correspondence: Dipartimento di Biopatologia e Metodologie Biomediche, Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy. E-mail: sireci{at}unipa.it

ABSTRACT

The NKT cell ligand -galactosylceramide and its synthetic homologue KRN7000 stimulate rapid and copious secretion of IFN- and TNF- release, both of which are key mediators of LPS-induced shock. We showed that KRN7000, injected before or within 2 h after LPS challenge, was able to prevent endotoxic shock. KRN7000 induced survival when the mice were injected 6, 9, or 12 days before the first injection of LPS, and this protective effect was associated with reduction upon subsequent challenge in the levels of IFN-, TNF-, MCP-1, and an increase of IL-10. Further analysis showed that the animals treated with KRN7000 prior to LPS challenge had lower numbers of F4/80⁺, NKT, and NK cells and lower percentages of NKT cells that stained for intracytoplasmic IFN- when compared with mice that were not treated with KRN7000. When MCP-1 was injected in KRN7000-treated mice, the lethal effect of LPS challenge was restored, and the numbers of F4/80⁺, NKT, and NK cells increased to levels similar to those in untreated mice following LPS challenge. Taken together, our data demonstrated that KRN7000, injected from 6 to 12 days before the first administration of LPS, prevented endotoxin shock by inhibiting IFN-, TNF-, and MCP-1 release.

Key Words: rodent • endotoxic • MCP-1 • NKT